 Munendra Tomar
Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Killer Cells, Natural | 3 | 2022 | 379 | 1.310 |
Why?
| | Lymphoma | 4 | 2022 | 178 | 1.170 |
Why?
| | Lymphoma, T-Cell | 3 | 2017 | 21 | 0.750 |
Why?
| | T-Lymphocytes, Regulatory | 2 | 2022 | 355 | 0.670 |
Why?
| | Tumor Microenvironment | 2 | 2022 | 449 | 0.300 |
Why?
| | Benzophenanthridines | 2 | 2015 | 10 | 0.270 |
Why?
| | Adenocarcinoma | 2 | 2022 | 790 | 0.260 |
Why?
| | Mice, Inbred BALB C | 6 | 2017 | 1185 | 0.250 |
Why?
| | Prostatic Neoplasms | 2 | 2022 | 938 | 0.250 |
Why?
| | Phytochemicals | 2 | 2021 | 7 | 0.240 |
Why?
| | Carcinogenesis | 3 | 2022 | 181 | 0.230 |
Why?
| | Cell Line, Tumor | 5 | 2022 | 2808 | 0.220 |
Why?
| | Apoptosis | 5 | 2017 | 2427 | 0.220 |
Why?
| | Azadirachta | 1 | 2022 | 4 | 0.220 |
Why?
| | Nanocapsules | 1 | 2022 | 8 | 0.220 |
Why?
| | Cation Transport Proteins | 1 | 2022 | 99 | 0.190 |
Why?
| | Small Molecule Libraries | 1 | 2021 | 81 | 0.190 |
Why?
| | Carica | 1 | 2020 | 2 | 0.190 |
Why?
| | Triple Negative Breast Neoplasms | 1 | 2022 | 159 | 0.180 |
Why?
| | Transforming Growth Factor beta | 1 | 2022 | 458 | 0.180 |
Why?
| | Protein Kinase C | 1 | 2021 | 285 | 0.180 |
Why?
| | Electromagnetic Radiation | 1 | 2019 | 2 | 0.170 |
Why?
| | Biological Products | 1 | 2021 | 173 | 0.160 |
Why?
| | Autoantigens | 2 | 2022 | 397 | 0.150 |
Why?
| | Cell Growth Processes | 1 | 2017 | 51 | 0.150 |
Why?
| | Protein Kinase C-alpha | 1 | 2017 | 42 | 0.150 |
Why?
| | Mice, Inbred DBA | 1 | 2017 | 172 | 0.150 |
Why?
| | Macrophages | 2 | 2016 | 1296 | 0.150 |
Why?
| | Antineoplastic Agents | 4 | 2015 | 1946 | 0.150 |
Why?
| | Neoplasm Transplantation | 1 | 2017 | 242 | 0.150 |
Why?
| | Interferon-gamma | 2 | 2017 | 732 | 0.140 |
Why?
| | Forkhead Transcription Factors | 1 | 2017 | 180 | 0.140 |
Why?
| | Tumor Cells, Cultured | 1 | 2017 | 861 | 0.130 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2016 | 72 | 0.130 |
Why?
| | Cell Proliferation | 4 | 2017 | 2232 | 0.130 |
Why?
| | Selenium | 1 | 2015 | 38 | 0.130 |
Why?
| | Tumor Burden | 1 | 2015 | 272 | 0.120 |
Why?
| | Mice | 7 | 2022 | 15289 | 0.120 |
Why?
| | Animals | 11 | 2022 | 32702 | 0.120 |
Why?
| | Metal Nanoparticles | 1 | 2015 | 73 | 0.120 |
Why?
| | Lymphocyte Activation | 1 | 2017 | 1063 | 0.110 |
Why?
| | Cell Survival | 2 | 2015 | 1029 | 0.110 |
Why?
| | Anxiety | 1 | 2019 | 838 | 0.110 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2012 | 159 | 0.100 |
Why?
| | Peptide Fragments | 1 | 2016 | 685 | 0.100 |
Why?
| | Stress, Psychological | 1 | 2019 | 953 | 0.100 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2015 | 440 | 0.100 |
Why?
| | Immunity, Cellular | 1 | 2012 | 267 | 0.100 |
Why?
| | Prostate | 2 | 2022 | 159 | 0.100 |
Why?
| | Humans | 12 | 2022 | 116809 | 0.090 |
Why?
| | Signal Transduction | 3 | 2021 | 4605 | 0.090 |
Why?
| | T-Lymphocytes | 1 | 2016 | 1769 | 0.080 |
Why?
| | DNA-Binding Proteins | 1 | 2013 | 1340 | 0.070 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2022 | 3348 | 0.070 |
Why?
| | Transcription Factors | 1 | 2013 | 1558 | 0.070 |
Why?
| | Male | 7 | 2022 | 56636 | 0.060 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2022 | 34 | 0.050 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2022 | 55 | 0.050 |
Why?
| | Transcriptional Regulator ERG | 1 | 2022 | 11 | 0.050 |
Why?
| | Islet Amyloid Polypeptide | 1 | 2022 | 47 | 0.050 |
Why?
| | Serine Endopeptidases | 1 | 2022 | 104 | 0.050 |
Why?
| | Aquatic Organisms | 1 | 2021 | 8 | 0.050 |
Why?
| | Allosteric Regulation | 1 | 2021 | 84 | 0.050 |
Why?
| | Carbon | 1 | 2022 | 166 | 0.050 |
Why?
| | Mice, Inbred NOD | 1 | 2022 | 569 | 0.050 |
Why?
| | Databases, Chemical | 1 | 2020 | 7 | 0.050 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2022 | 177 | 0.050 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2021 | 279 | 0.040 |
Why?
| | Neoplasms | 1 | 2013 | 2144 | 0.040 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2022 | 311 | 0.040 |
Why?
| | Plant Leaves | 1 | 2020 | 118 | 0.040 |
Why?
| | Maze Learning | 1 | 2019 | 85 | 0.040 |
Why?
| | Zinc | 1 | 2022 | 260 | 0.040 |
Why?
| | Molecular Structure | 1 | 2020 | 437 | 0.040 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2020 | 180 | 0.040 |
Why?
| | Amino Acids | 1 | 2022 | 460 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2015 | 1155 | 0.040 |
Why?
| | Immunologic Factors | 1 | 2020 | 223 | 0.040 |
Why?
| | Corticosterone | 1 | 2019 | 250 | 0.040 |
Why?
| | Amygdala | 1 | 2019 | 172 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2022 | 723 | 0.040 |
Why?
| | Cell Death | 1 | 2019 | 332 | 0.040 |
Why?
| | Hydrolysis | 1 | 2017 | 177 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 1 | 2020 | 456 | 0.040 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2022 | 977 | 0.040 |
Why?
| | CD28 Antigens | 1 | 2016 | 46 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2017 | 428 | 0.030 |
Why?
| | Protein Transport | 1 | 2017 | 406 | 0.030 |
Why?
| | Staurosporine | 1 | 2015 | 21 | 0.030 |
Why?
| | Caspase 9 | 1 | 2015 | 49 | 0.030 |
Why?
| | Protein Structure, Tertiary | 1 | 2017 | 819 | 0.030 |
Why?
| | Macrophage Activation | 1 | 2016 | 164 | 0.030 |
Why?
| | Cytochromes c | 1 | 2015 | 63 | 0.030 |
Why?
| | Interleukin-2 | 1 | 2016 | 416 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2017 | 468 | 0.030 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2015 | 186 | 0.030 |
Why?
| | Cell Communication | 1 | 2016 | 277 | 0.030 |
Why?
| | Disease Progression | 1 | 2021 | 2466 | 0.030 |
Why?
| | Heat Shock Transcription Factors | 1 | 2013 | 17 | 0.030 |
Why?
| | Caspase 3 | 1 | 2015 | 237 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2015 | 515 | 0.030 |
Why?
| | Particle Size | 1 | 2015 | 342 | 0.030 |
Why?
| | Surface Properties | 1 | 2015 | 388 | 0.030 |
Why?
| | Cell Movement | 1 | 2017 | 879 | 0.030 |
Why?
| | RNA Interference | 1 | 2015 | 451 | 0.030 |
Why?
| | Culture Media, Conditioned | 1 | 2012 | 107 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 963 | 0.030 |
Why?
| | Models, Molecular | 1 | 2017 | 1408 | 0.030 |
Why?
| | Blotting, Western | 1 | 2015 | 1168 | 0.030 |
Why?
| | Survival Rate | 1 | 2015 | 1681 | 0.020 |
Why?
| | Molecular Targeted Therapy | 1 | 2013 | 352 | 0.020 |
Why?
| | Rats | 1 | 2019 | 5177 | 0.020 |
Why?
| | Phosphorylation | 1 | 2015 | 1591 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2015 | 1893 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2012 | 1066 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2016 | 1732 | 0.020 |
Why?
| | Time Factors | 1 | 2019 | 6248 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2012 | 3962 | 0.020 |
Why?
| | Female | 3 | 2015 | 60542 | 0.010 |
Why?
|
|
Tomar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|